Kevin Martinez, MD
Interventional Pain Medicine · Metairie, LANPI 1700800828
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $214 and has fallen 76.4% since, to $50 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in LA, where the typical reported total is $4,761.
Across 15 payments — averaging $24.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$71
- Boston Scientific$64
- ALON Medical Technology$51
- Virtus Pharmaceuticals LLC$34
- Nevro Corp.$31
- Pfizer$25
- plus $87 from 5 others
What the payments were for
- Food & beverage$363100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $71 |
| Boston Scientific | 1 | $64 |
| ALON Medical Technology | 1 | $51 |
| Virtus Pharmaceuticals LLC | 2 | $34 |
| Nevro Corp. | 1 | $31 |
| Pfizer | 2 | $25 |
| Nalu Medical, Inc. | 1 | $22 |
| Globus Medical | 1 | $22 |
| IBSA Pharma Inc. | 1 | $21 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Relievant Medsystems, Inc. | 1 | $6 |
How this compares
$363 in reported general payments places this provider in the 5th percentile of 57 interventional pain medicine providers in Louisiana.
See all interventional pain medicine providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 11 | $4,383 |
| Xtampza ErOxycodone Myristate | 12 | $4,317 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 129 | $1,950 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 68 | $1,719 |
| Fentanyl | 13 | $1,139 |
| Cyclobenzaprine Hcl ErCyclobenzaprine Hcl | 11 | $1,105 |
| Gabapentin | 80 | $828 |
| Tramadol Hcl | 74 | $686 |
| Pregabalin | 30 | $347 |
| Oxycodone Hcl | 13 | $197 |
| Methocarbamol | 19 | $90 |
| Eszopiclone | 12 | $85 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Metairie
- Paul HubbellMetairie$33K
- Eric LonsethMetairie$8K
- Robert McMyneMetairie$5K
- Barry FaustMetairie$4K
- Joseph CrapanzanoMetairie$1K
- Peter ZimmermanMetairie$38
- Maged GuirguisNew Orleans$565K
- Suneil JollyKenner$107K
- John CefaluShreveport$71K
- Steve LeeSlidell$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.